Company Filing History:
Years Active: 2002
Title: Berhnard Kleter: Innovator in HPV Detection
Introduction
Berhnard Kleter is a notable inventor based in Delft, Netherlands. He has made significant contributions to the field of medical diagnostics, particularly in the detection of human papillomavirus (HPV). His innovative work has implications for public health and disease prevention.
Latest Patents
Kleter holds a patent for a method of detection and identification of HPV present on biological samples. The patent, titled "Detection and identification of human papillomavirus by PCR and type-specific reverse hybridization," describes a process that involves the amplification of HPV polynucleic acids and hybridization to specific probes. This method utilizes PCR to amplify a short fragment of the L1 gene of HPV, which is then hybridized with probes that can identify one or more HPV types. The invention also includes primers and probes for detection and a diagnostic kit for practical application.
Career Highlights
Throughout his career, Berhnard Kleter has been associated with Innogenetics, S.A., a company known for its advancements in molecular diagnostics. His work has been pivotal in enhancing the accuracy and efficiency of HPV detection methods, contributing to better healthcare outcomes.
Collaborations
Kleter has collaborated with notable colleagues, including Leen-Jan Van Doorn and Wim Quint. These partnerships have fostered innovation and have been instrumental in the development of effective diagnostic techniques.
Conclusion
Berhnard Kleter's contributions to HPV detection exemplify the impact of innovative thinking in medical diagnostics. His work continues to influence the field and improve health outcomes for individuals at risk of HPV-related diseases.